All toxicology data, as described in paragraph (c) of this section, must be submitted to support a request for an experimental use permit.
(a) Use patterns.
(1) Food use patterns include products classified under the general use patterns of terrestrial food crop use, terrestrial feed crop use, aquatic food crop use, greenhouse food crop use, and indoor food use.
(2) Nonfood use patterns include products classified under the general use patterns of terrestrial nonfood crop use, aquatic nonfood crop use, aquatic nonfood outdoor use, greenhouse nonfood crop use, forestry use, residential outdoor use, indoor nonfood use, and indoor residential use.
(b) Key. CR = Conditionally required; NR = Not required; R = Required; EP = End-use product; MP = Manufacturing-use product; PAIRA = Pure active ingredient radio-labeled; TGAI = Technical grade of the active ingredient.
(c) Table. The following table shows the experimental use data requirements for toxicology. The test notes are shown in paragraph (d) of this section.
Table - Experimental Use Permit Toxicity Data Requirements
| Guideline Number | Data Requirement | Use Pattern | Test substance to support | Test Note No. | ||
|---|---|---|---|---|---|---|
| Food | Nonfood | MP | EP | |||
| Acute Testing | ||||||
| 870.1100 | Acute oral toxicity - rat | R | R | MP and TGAI | TGAI, EP | 1 |
| 870.1200 | Acute dermal toxicity | R | R | MP and TGAI | TGAI, EP | 1, 2 |
| 870.1300 | Acute inhalation toxicity - rat | R | R | MP and TGAI | TGAI and EP | 3 |
| 870.2400 | Primary eye irritation - rabbit | R | R | MP | TGAI and EP | 2 |
| 870.2500 | Primary dermal irritation | R | R | MP | TGAI and EP | 1, 2 |
| 870.2600 | Dermal sensitization | R | R | MP | TGAI and EP | 2, 4 |
| 870.6100 | Delayed neurotoxicity (acute) - hen | CR | CR | TGAI | TGAI | 5 |
| Subchronic Testing | ||||||
| 870.3100 | 90-day Oral - rodent | R | NR | TGAI | TGAI | - |
| 870.3150 | 90-day Oral - non-rodent | R | NR | TGAI | TGAI | - |
| Chronic Testing | ||||||
| 870.4100 | Chronic oral - rodent | R | NR | TGAI | TGAI | 6 |
| Developmental Toxicity and Reproduction | ||||||
| 870.3700 | Prenatal Developmental toxicity - rat and rabbit, preferred | R | NR | TGAI | TGAI | 7, 8 |
| 870.3800 | Reproduction | R | NR | TGAI | TGAI | 6 |
| Mutagenicity Testing | ||||||
| 870.5100 | Bacterial reverse mutation assay | R | NR | TGAI | TGAI | 9 |
| 870.5300 870.5375 |
In vitro mammalian cell assay | R | NR | TGAI | TGAI | 9, 10 |
| 870.5385 870.5395 |
In vivo cytogenetics | R | NR | TGAI | TGAI | 9, 11 |
(d) Test notes. The following test notes apply to the data requirements in the table to paragraph (c) of this section.
1. Not required if test material is a gas or a highly volatile liquid.
2. Not required if test material is corrosive to skin or has a pH of less than 2 or greater than 11.5.
3. Required if the product consists of, or under conditions of use will result in, a respirable material (e.g., gas, vapor, aerosol, or particulate).
4. Required if repeated dermal exposure is likely to occur under conditions of use.
5. Required if the test material is an organophosphorus substance, which includes uncharged organophosphorus esters, thioesters, or anhydrides of organophosphoric, organophosphonic, or organophosphoramidic acids, or of related phosphorothioic, phosponothioic, or phosphorothioamidic acids, or is structurally related to other substances that may cause the delayed neurotoxicity sometimes seen in this class of chemicals.
6. These studies are seldom required to support EUPs. They may be required if the dietary exposure for these EUPs occupies a large part, e.g., greater than 50%, of the reference dose.
7. The oral route, by oral intubation, is preferred unless the chemical or physical properties of the test substance or the pattern of exposure suggests a more appropriate route of exposure.
8. May be combined with the 2-generation reproduction study in rodents by utilizing a second mating of the parental animals in either generation.
9. At a minimum, an initial battery of mutagenicity tests with possible confirmatory testing is required. Other relevant mutagenicity tests that may have been performed, plus a complete reference list must also be submitted.
10. Choice of assay using either:
i. Mouse lymphoma L5178Y cells, thymidine kinase (tk) gene locus, maximizing assay conditions for small colony expression or detection;
ii. Chinese hamster ovary (CHO) or Chinese hamster lung fibroblast (V79) cells, hypoxanthine-guanine phosphoribosyl transferase (hgprt) gene locus, accompanied by an appropriate in vitro test for clastogenicity; or
iii. CHO cells strains AS52, xanthine-guanine phosphoribosyl transferase (xprt) gene locus.
11. The micronucleus rodent bone marrow assay is preferred; however, rodent bone marrow assays using metaphase analysis (aberrations) are acceptable.
[72 FR 60957, Oct. 26, 2007, as amended at 73 FR 75596, Dec. 12, 2008]